Actively Recruiting
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Led by Sohag University · Updated on 2025-05-01
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the relationship between serum albumin levels and the severity of hepatic encephalopathy in patients with chronic liver disease. It also seeks to understand how albumin levels affect the clinical course and outcomes of hepatic encephalopathy. The study plans to include 100 to 150 patients to ensure reliable statistical results. Participants will undergo a thorough clinical assessment including Glasgow Coma Scale scoring and evaluation of chronic liver disease complications such as ascites and variceal bleeding. Medical history details such as prior hepatic encephalopathy episodes, liver disease causes, and other health conditions will be recorded. Laboratory tests will measure serum albumin, liver enzymes, bilirubin, blood counts, kidney function, and blood clotting parameters. During the study, researchers will collect and analyze clinical and laboratory data to assess correlations. The primary outcome is the correlation between serum albumin levels and hepatic encephalopathy severity over a six-month period. Participants will be monitored carefully to understand how albumin impacts their disease progression and clinical outcomes.
CONDITIONS
Brief Title
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged over 18 years
- Confirmed chronic liver disease by imaging, liver function tests, and clinical history
- Diagnosed with hepatic encephalopathy based on clinical criteria
- Patients able to provide informed consent
You will not qualify if you...
- Patients under 18 years of age
- Acute liver failure
- Chronic renal failure on dialysis
- Pregnant women
- Patients with active malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Baseline
Participants undergo initial clinical assessments and laboratory investigations to evaluate chronic liver disease and hepatic encephalopathy severity.
1 visit (in-person)
Duration - 6 months
Participants are observed over time to assess the correlation between serum albumin levels and the severity of hepatic encephalopathy.
Trial Site Locations
Total: 1 location
1
Sohag university hospital
Sohag, Egypt
Actively Recruiting
Research Team
K
Kerelos L Sweha, Resident
H
Hamdy S Mohamed, Assist.prof
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here